These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 10430212)
21. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536 [TBL] [Abstract][Full Text] [Related]
22. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Bower M; Palmieri C; Dhillon T Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212 [TBL] [Abstract][Full Text] [Related]
23. Less cancer--or more--with HAART? Or, reflections on a late opus. Mascolini M J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531 [TBL] [Abstract][Full Text] [Related]
24. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP; Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354 [TBL] [Abstract][Full Text] [Related]
25. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Cook-Mozaffari P; Newton R; Beral V; Burkitt DP Br J Cancer; 1998 Dec; 78(11):1521-8. PubMed ID: 9836488 [TBL] [Abstract][Full Text] [Related]
26. AIDS malignancies in the era of highly active antiretroviral therapy. Gates AE; Kaplan LD Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891 [TBL] [Abstract][Full Text] [Related]
27. The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996. Pezzotti P; Serraino D; Rezza G; Dal Maso L; Vaccher E; Lepri AC; Franceschi S Int J Epidemiol; 1999 Oct; 28(5):975-81. PubMed ID: 10597999 [TBL] [Abstract][Full Text] [Related]
28. AIDS malignancies in the era of highly active antiretroviral therapy. Gates AE; Kaplan LD Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534 [TBL] [Abstract][Full Text] [Related]
29. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada. Bahl S; Theis B; Nishri D; Marrett LD Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279 [TBL] [Abstract][Full Text] [Related]
30. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. Parkin DM; Wabinga H; Nambooze S; Wabwire-Mangen F AIDS; 1999 Dec; 13(18):2563-70. PubMed ID: 10630526 [TBL] [Abstract][Full Text] [Related]
31. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978 [TBL] [Abstract][Full Text] [Related]
32. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. Lyter DW; Bryant J; Thackeray R; Rinaldo CR; Kingsley LA J Clin Oncol; 1995 Oct; 13(10):2540-6. PubMed ID: 7595705 [TBL] [Abstract][Full Text] [Related]
33. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Ives NJ; Gazzard BG; Easterbrook PJ J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320 [TBL] [Abstract][Full Text] [Related]
34. AIDS-related cancers in the era of highly active antiretroviral therapy. Biggar RJ Oncology (Williston Park); 2001 Apr; 15(4):439-48; discussion 448-9. PubMed ID: 11346932 [TBL] [Abstract][Full Text] [Related]
35. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. Franceschi S; Dal Maso L; Pezzotti P; Polesel J; Braga C; Piselli P; Serraino D; Tagliabue G; Federico M; Ferretti S; De Lisi V; La Rosa F; Conti E; Budroni M; Vicario G; Piffer S; Pannelli F; Giacomin A; Bellù F; Tumino R; Fusco M; Rezza G; J Acquir Immune Defic Syndr; 2003 Sep; 34(1):84-90. PubMed ID: 14501799 [TBL] [Abstract][Full Text] [Related]
36. AIDS-defining cancers in Western Europe, 1994-2001. Ebrahim SH; Abdullah AS; McKenna M; Hamers FF AIDS Patient Care STDS; 2004 Sep; 18(9):501-8. PubMed ID: 15630770 [TBL] [Abstract][Full Text] [Related]
37. AIDS related malignant disease at regional institute of medical sciences. Gatphoh ED; Zamzachin G; Devi SB; Punyabati P Indian J Pathol Microbiol; 2001 Jan; 44(1):1-4. PubMed ID: 12561985 [TBL] [Abstract][Full Text] [Related]
38. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. Ledergerber B; Telenti A; Egger M BMJ; 1999 Jul; 319(7201):23-4. PubMed ID: 10390454 [No Abstract] [Full Text] [Related]
39. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States. Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786 [TBL] [Abstract][Full Text] [Related]
40. Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Rabkin CS; Biggar RJ; Baptiste MS; Abe T; Kohler BA; Nasca PC Int J Cancer; 1993 Sep; 55(2):208-12. PubMed ID: 8370617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]